NCT06884761 Routine Activity and Preterm Delivery Risk in Women With a Short Cervix
| NCT ID | NCT06884761 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wolfson Medical Center |
| Condition | Cervical Shortening |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-15 |
| Primary Completion | 2027-12-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-01-15 with a primary completion date of 2027-12-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the effect of routine activity versus rest on the risk of preterm delivery in pregnant women with a short cervix diagnosed between 24 and 34 weeks of gestation. The main questions it aims to answer are: Does routine activity influence the gestational age at delivery? How does routine activity affect secondary outcomes such as preterm labor, premature rupture of membranes, delivery mode, maternal anxiety, and satisfaction? Researchers will compare women instructed to maintain routine activity (control group) to women advised to practice maximal rest (intervention group) to see if physical activity impacts preterm birth outcomes. Participants will: Wear a smart band to monitor step counts over a two-week period. Be randomized into two groups: one encouraged to maintain routine activity and the other advised to follow strict rest protocols. Undergo regular follow-ups at a high-risk pregnancy clinic and have their data collected through hospital records and smart band tracking. This randomized controlled trial will assess gestational age at delivery as the primary outcome, along with secondary maternal and neonatal outcomes, providing insight into the role of physical activity in managing pregnancies complicated by a short cervix.
Eligibility Criteria
Inclusion Criteria: * Singleton pregnancies between 24+0 and 34+6 weeks. * Short cervical length (\<25 mm) confirmed via transvaginal ultrasound. * No medical contraindications to physical activity. Exclusion Criteria: * Twin pregnancies or higher-order multiples. * Medical indications for reduced mobility (e.g., symphysiolysis, fall risk). * Maternal comorbidities, fetal distress, vaginal bleeding, PPROM, or need for immediate delivery.
Frequently Asked Questions
Who can join the NCT06884761 clinical trial?
This trial is open to female participants only, studying Cervical Shortening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06884761 currently recruiting?
Yes, NCT06884761 is actively recruiting participants. Visit ClinicalTrials.gov or contact Wolfson Medical Center to inquire about joining.
Where is the NCT06884761 trial being conducted?
This trial is being conducted at Holon, Israel.
Who is sponsoring the NCT06884761 clinical trial?
NCT06884761 is sponsored by Wolfson Medical Center. The trial plans to enroll 100 participants.